Executive search firm Toft Group has placed Mr. Sashi Tripathi as Chief Technology Officer at ImpediMed Ltd. (ASX: IPD), in ImpediMed’s US office in Carlsbad, CA.
Mr. Tripathi is an accomplished healthcare technology leader. As the SVP of Technology & Operations of New Century Health, he oversaw all aspects of IT, project and product management, product development and operations. He joined New Century Health from Springfield Clinic where he was the Chief Information Officer responsible for strategy, development, management and integration of the organization. Previously, Mr. Tripathi was the VP of IT for Facey Medical.
Earlier in his industry career, Mr. Tripathi served as a Product Development Consultant for Agnity Healthcare and as Global IT Director for St. Jude Medical. Mr. Tripathi holds an MS in Industrial Engineering & Operations Research from the Indian Institute of Technology and a BE in Mechanical Engineering from M.M.M. Engineering College.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
About ImpediMed, Ltd.
Founded and headquartered in Brisbane, Australia with US and European operations, ImpediMed is the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of tissue composition and fluid status. ImpediMed produces a family of FDA cleared and CE Marked medical devices, including SOZO® for multiple indications including heart failure and lymphoedema, sold in select markets globally.